Scott Minor

NYC resident, father of a child with diabetes, advocate for research to prevent, better treat, and cure type 1 diabetes

[Scott Minor @SMinorNYC]

Thank Senator Schumer for Championing T1D Research Funding - Breakthrough T1D https://t.co/IosMW2GBGp

[Scott Minor @SMinorNYC]

Thank you @RepJerryNadler for your steadfast support of the #T1D community! #GovDay2024 #BreakthroughT1D

[Rep. Nadler @RepJerryNadler]

Today, it was my pleasure to meet with Breakthrough T1D to discuss capping the price of insulin, fully funding the special diabetes program, and exciting developments in cell and gene therapy research.

[Ad Age @adage]

For JDRF, a leading organization funding Type 1 diabetes research, it was time for a change—specifically a name change. https://t.co/Qhs3LaC6Th

[Breakthrough T1D @BreakthroughT1D]

Same mission, New name. Breakthrough T1D (formerly JDRF) is the world leader in T1D research, advocacy, and community support. Our new brand reflects our bold vision for a world without T1D. We are accelerating breakthroughs and building a movement for change. #BreakthroughT1D

[Scott Minor @SMinorNYC]

Thank Congress for Supporting T1D Research Funding - JDRF https://t.co/PZKdOSooqT

[T1DinNYC @T1DinNYC]

DC bound and ready to advocate! #JDRFCC2023

[T1DinNYC @T1DinNYC]

Thank you to Jesse from @SenGillibrand's office for meeting with #JDRF Advocates from New York State. We had a great discussion about #SDP research funding and insulin affordability. #JDRFGovDay

[T1DinNYC @T1DinNYC]

It is always an honor to talk to @SenSchumer about living with #T1D and insulin affordability. We are grateful for his support for the #INSULINAct. @JDRFAdvocacy @JDRFgnyc

[T1DinNYC @T1DinNYC]

It was an honor for @JDRF New York Advocates to attend @SenSchumer's press conference about insulin affordability. Thank you Senator for all your work and support for the #INSULINAct. @JDRFAdvocacy @JDRFgnyc

[Scott Minor @SMinorNYC]

Today I asked my daughter’s endo NOT to analyze her CGM data because @Cigna and @nbdiabetes can’t align on a covered billing code. After a year of calls and e-mails and collection notices on disputed amounts, we had no other choice. #EpicFail #Unhealthy

[Scott Minor @SMinorNYC]

@Vanguard_Group Thank you. That’s helpful.

[Scott Minor @SMinorNYC]

@Vanguard_Group I’d even take a call back when an agent is available. @Delta does that and I love it!

[Scott Minor @SMinorNYC]

@Vanguard_Group @Vanguard_Group After 2 hour hold, learned we were holding for the wrong department! #Inept

[Scott Minor @SMinorNYC]

@Vanguard_Group Help! Been on hold for 90 minutes with @Vanguard_Group to get a letter needed to transfer money, not available on the app or website. It’s never been so hard to become a customer! #EpicFail

[The Hill @thehill]

Drugmaker caps insulin costs at $35 to help diabetes patients during pandemic https://t.co/S2Ly5z2sx3

[Breakthrough T1D @BreakthroughT1D]

A concerning trend is limits being placed on the choice of device, similar to the way insurance companies restrict drug choice. At least one insurer -- @UHC (UnitedHealthcare) -- has decided to limit coverage to a single insulin pump manufacturer.

[Beto O'Rourke @BetoORourke]

Insulin costs $450 a month. An AR-15 costs $395 for a lifetime. It shouldn’t be more affordable to kill than to stay alive.

[Scott Minor @SMinorNYC]

Why Alphabet, Amazon and Apple are all working on diabetes tech https://t.co/jFJixKNXci

[Scott Minor @SMinorNYC]

Thank you @RepMaxRose for taking time to meet with some of your JDRF families. The #Type1Diabetes community appreciates your support! @JDRFAdvocacy #JDRFNewMember